Organogenesis Holdings Inc. ORGO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.16M-222% | $43.7M+103% | $21.57M+330% | -$9.39M+50.2% | -$18.84M-346% | ||
| $4.17M+2.7% | $4.07M+0.9% | $4.03M+7.9% | $3.73M+8.4% | $3.44M-4.7% | ||
| $3.64M-15.9% | $4.32M+41.1% | $3.07M+20.6% | $2.54M-24.5% | $3.37M+16.5% | ||
| -$15.37M-198% | $15.63M+507% | -$3.84M-274% | -$1.03M+19.0% | -$1.27M+55.3% | ||
| —— | -$115K-297% | -$29K-16.0% | -$25K-31.6% | -$19K+97.3% | ||
| -$104.5M-303% | $51.48M+1.6% | $50.69M+163% | $19.31M+441% | -$5.67M-164% | ||
| $8.73M+195% | $2.96M— | $0-100% | $7.16M-18.0% | $8.73M+1,819% | ||
| -$2M-71.1% | -$1.17M-17.8% | -$994K-124% | $4.13M+266% | -$2.5M— | ||
| $1.66M— | —— | —— | $7.82M+52.6% | $5.12M— | ||
| $293K— | —— | $1.43M— | —— | —— | ||
| $5.71M+615% | $798K-5.2% | $842K+0.1% | $841K-0.1% | $842K+1.0% | ||
| $2.49M+15.8% | $2.15M+1.6% | $2.12M+1.7% | $2.08M+4.2% | $2M+1.3% | ||
| $21.13M— | —— | —— | -$32.87M-64.9% | -$19.94M-282% | ||
| $3.15M-32.4% | $4.65M+108% | $2.24M-38.6% | $3.64M+0.3% | $3.63M+7.9% | ||
| -$3.15M+32.4% | -$4.65M-108% | -$2.24M+38.6% | -$3.64M-0.3% | -$3.63M-7.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2K-98.5% | $130K— | $0-100% | $25K-97.6% | ||
| $9.84M+3,158% | $302K+2.0% | $296K+2.8% | $288K+1.1% | $285K+2.9% | ||
| $3.05M+3,407% | $87K+4,250% | $2K— | $0-100% | $1.8M+89,700% | ||
| —— | —— | —— | —— | —— | ||
| -$20.21M-320% | -$4.81M+52.9% | -$10.21M-3,444% | -$288K+86.0% | -$2.06M-106% | ||
| -$2.23M— | —— | -$9.36M+74.6% | -$36.8M-43.7% | -$25.62M-162% | ||
| —— | —— | —— | —— | —— | ||
| —— | $1.26M+327% | $295K-91.9% | $3.64M+2,327% | $150K-89.8% | ||
| -$6.99M+5.4% | -$7.39M-295% | -$1.87M+21.6% | -$2.38M+35.7% | -$3.71M-59.5% | ||
| $5.71M+615% | $798K-5.2% | $842K+0.1% | $841K-0.1% | $842K+1.0% | ||
| —— | —— | —— | —— | —— | ||
| -$19.48M-258% | $12.32M+3.2% | $11.94M+303% | -$5.89M+26.3% | -$7.99M-344% | ||
| $2.4M+9.6% | $2.19M+1.6% | $2.16M+2.1% | $2.11M+3.6% | $2.04M-57.7% | ||
| $1.66M— | —— | —— | $7.82M+52.6% | $5.12M— | ||
| $91K-45.5% | $167K+142% | $69K-1.4% | $70K+1.4% | $69K-14.8% | ||
| $2.49M+15.8% | $2.15M+1.6% | $2.12M+1.7% | $2.08M+4.2% | $2M+1.3% | ||
| -$3.96M-241% | $2.81M+22.9% | $2.29M+2.0% | $2.24M+157% | $873K+306% | ||
| —— | $1.94M+110% | $922K-47.2% | $1.75M-73.4% | $6.57M— | ||
| $7.32M+103% | $3.62M0.0% | $3.62M0.0% | $3.62M0.0% | $3.62M— | ||
| $9.84M+3,158% | $302K+2.0% | $296K+2.8% | $288K+1.1% | $285K+2.9% | ||
| —— | —— | —— | —— | —— | ||
| $3M+2.2% | $2.94M+2.2% | $2.87M+2.3% | $2.81M+2.3% | $2.75M+511% | ||
| $39K-98.6% | $2.74M— | —— | —— | $172K+182% | ||
| $4.07M— | —— | —— | —— | —— | ||
| —— | $672.75K0.0% | $672.75K0.0% | $672.75K0.0% | $672.75K— | ||
| —— | —— | —— | —— | —— | ||
| $483K-97.5% | $19.22M— | —— | —— | —— | ||
| —— | $24.59M+4,192% | $573K+231% | $173K-89.5% | $1.64M-58.0% | ||
| $17.98M— | —— | —— | -$36.51M-55.0% | -$23.56M-411% | ||
| $17.98M— | —— | —— | -$36.51M-55.0% | -$23.56M-411% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Organogenesis Holdings Inc. generate?
- Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
- What is Organogenesis Holdings Inc.'s free cash flow?
- After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
- Where does Organogenesis Holdings Inc.'s cash flow data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
